Niagen Bioscience (stock code: NAGE) recently announced its financial results for fiscal year 2025, delivering an impressive performance.

老虎证券2026/03/04 21:12

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

The company's net sales reached $129.4 million, representing a significant 30% increase compared to the same period last year. In terms of profitability, there was an even more remarkable leap, with net profit recorded at $17.4 million, soaring 103% year-on-year. Based on basic earnings per share, the company achieved earnings of $0.22 per share in fiscal year 2025. This strong growth momentum was mainly driven by sustained robust demand for core products in the market and a significant improvement in the company's operational efficiency.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The Japanese Finance Minister stated that Ms. Komei herself has repeatedly requested her to clarify this position to overseas investors. This statement attempts to dispel the market’s perception that the Komei government interferes with the central bank or pursues a loose monetary policy. Last Wednesday, two committee members nominated by Komei opposed a Bank of Japan interest rate hike, further reinforcing the market’s view that the Japanese government tends to delay rate increases.

华尔街见闻•2026/09/25 22:26

HIFI Raises $37M Series A to Build Settlement Rails for Tokenized Money

Cryptopotato•2026/09/25 22:06